Business News • PR NewsWire • GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant

GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant

GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant

YONGIN, South Korea, Feb. 13, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, and Lee's Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee's Pharmaceutical Holdings Limited ("Lee's Pharm")...

View More : https://www.prnewswire.com/news-releases/gc-pharma-and-lees-pharm-enter-into-china-licensing-agreement-to-develop-and-co...

Releted News by prnewswire

Two Thirds of Middle East Bank CEOs at Risk of Losing Jobs According to Metin Mitchell Research

Clorox Increases Quarterly Dividend 14 Percent to 96 Cents Per Share From Tax Reform Benefits